Evidence map›Paper›PMID 42853660›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Dystrophic changes of nigrostriatal axons harboring a

Yumei Wu, Peng Xu, James Moran, C Shan Xu, Kenneth J Hayworth, Mian Cao, Lin Shao, D James Surmeier, Harald F Hess, Pietro De Camilli

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Dystrophic changes of nigrostriatal axons harboring aProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Yumei WuDepartments of Neuroscience and of Cell Biology, Program in Cellular Neuroscience, Neurodegeneration, and Repair and HHMI, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0003-0878-7605
Peng XuDepartments of Neuroscience and of Cell Biology, Program in Cellular Neuroscience, Neurodegeneration, and Repair and HHMI, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0001-5197-9560
James MoranAligning Science Across Parkinson's, Collaborative Research Network, Chevy Chase, MD 20815.ORCID 0000-0003-4517-4349
C Shan XuJanelia Research Campus, HHMI, Ashburn, VA 20147.ORCID 0000-0002-8564-7836
Kenneth J HayworthJanelia Research Campus, HHMI, Ashburn, VA 20147.ORCID 0000-0002-6467-7024
Mian CaoDepartments of Neuroscience and of Cell Biology, Program in Cellular Neuroscience, Neurodegeneration, and Repair and HHMI, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0002-8519-6764
Lin ShaoCenter for Neurodevelopment and Plasticity, Wu Tsai Institute, Yale University, New Haven, CT 06510.ORCID 0000-0002-1905-4442
D James SurmeierAligning Science Across Parkinson's, Collaborative Research Network, Chevy Chase, MD 20815.ORCID 0000-0002-6376-5225
Harald F HessJanelia Research Campus, HHMI, Ashburn, VA 20147.ORCID 0000-0003-3000-1533
Pietro De CamilliDepartments of Neuroscience and of Cell Biology, Program in Cellular Neuroscience, Neurodegeneration, and Repair and HHMI, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0001-9045-0723

Funding

Yale/NIDA Neuroproteomics Research CenterP30DA018343 · NIDA · YALE UNIVERSITY · PI ANGUS C. NAIRN, Kenneth Robert WILLIAMS · 2004 to 2026
$37.1M
Aligning Science Across Parkinson's (ASAP) ASAP-000580Aligning Science Across Parkinson's (ASAP) ASAP-020551Freedom Together Foundation (FTF) 2024-4715HHMI (HHMI) not applicableHHS | NIH | National Institute on Drug Abuse (NIDA) DA018343NIDA NIH HHS P30 DA018343Parkinson's Foundation (PF) PF-RCE-1946
6 · The paper itself

Abstract

Synaptojanin 1 is a brain enriched phosphoinositide phosphatase implicated in endocytosis at the synapse. A mutation (R258Q) that selectively impairs its Sac1 phosphatase domain causes early onset familial Parkinsonism. Neurons of mice with this mutation display synaptic vesicle traffic defects across the brain, but selective dystrophic changes in a subset of dopaminergic axons in the dorsolateral striatum. Using correlative light microscopy-FIB-SEM of mutant mouse striata to visualize in 3D these abnormal structures we show that they represent clusters of focal axonal dilations harboring massive, onion-like DAT enriched plasma membrane infoldings, generally localized next to cell bodies of neighboring cells, often engulfing evaginations of such cells. This dysmorphia was associated with a deficit in dopamine release in the same striatal region. Given the involvement of Synj1 in endocytic mechanisms, these structures may reflect an imbalance between exocytosis and endocytosis. Their occurrence only in a subset of axons suggests a vulnerability threshold of these axons beyond which the expansion of the plasma membrane is not counteracted by compensatory mechanisms.

Indexed as

AxonsCorpus StriatumEndocytosisMutationNerve Tissue ProteinsParkinson DiseasePhosphoric Monoester HydrolasesSubstantia NigraAnimalsCell MembraneDopamineMicePhosphoinositide 5-PhosphatasesSynaptic VesiclesDopamineNerve Tissue ProteinsPhosphoinositide 5-PhosphatasesPhosphoric Monoester Hydrolasessynaptojaninauxilindopamine transporterendocytic recyclingParkinson’s diseasesynaptojanin

Identifiers

PMID42853660
PMCPMC13663811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.